ArticleBiochemistry and biophysics reports2025
Clinical data investigation identifies MARK3 as an oncogenic driver in castration-resistant prostate cancer.
Rajnikant Raut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it